Literature DB >> 2676086

Gene therapy for genetic diseases.

D B Kohn1, W F Anderson, R M Blaese.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676086     DOI: 10.3109/07357908909038283

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  7 in total

1.  Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion.

Authors:  P Olson; H M Temin; R Dornburg
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

Review 2.  Cellular transplantation and gene therapy.

Authors:  C Ricordi; S T Ildstad; T E Starzl
Journal:  Clin Transplant       Date:  1993-02       Impact factor: 2.863

3.  Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects.

Authors:  G Grassi; A Forlino; J C Marini
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

4.  Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer.

Authors:  T H Chu; R Dornburg
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

5.  Improved self-inactivating retroviral vectors derived from spleen necrosis virus.

Authors:  P Olson; S Nelson; R Dornburg
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells.

Authors:  Yin-He Wang; Zhao-Xia Wang; Yong Qiu; Jin Xiong; Yi-Xin Chen; Deng-Shun Miao; Wei De
Journal:  Mol Cell Biochem       Date:  2009-02-20       Impact factor: 3.396

7.  Lysine: Is it worth more?

Authors:  D Datta; A Bhinge; V Chandran
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.